Optiver Holding
LAB icon

Optiver Holding’s Standard BioTools LAB Stock Holding History

Optiver Holding’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.24K Buy
1,350
+972
+257% +$1.18K ﹤0.01% 2011
2025
Q4 		$484 Sell
378
-3,486
-90% -$4.68K ﹤0.01% 2298
2025
Q3 		$5.02K Buy
+3,864
New +$5.06K ﹤0.01% 1734

Other funds holding LAB

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Optiver Holding's LAB Position: Q1 2026 in Review

Optiver Holding increased its Standard BioTools (LAB) stake by 257% in Q1 2026, buying an estimated $1.18K and bringing the position to 1,350 shares worth $1.24K. The position accounts for ﹤0.01% of the portfolio, ranked #2011.

Optiver Holding first reported a position in LAB in Q3 2025 and has held it in 3 quarters since. The position peaked at $5.02K in Q3 2025. 155 funds tracked by Wall St. Rank hold LAB as of Q1 2026.

  • Optiver Holding held 1,350 shares of Standard BioTools worth $1.24K as of Q1 2026.
  • Optiver Holding bought 972 Standard BioTools shares in Q1 2026, an estimated $1.18K.
  • Standard BioTools made up ﹤0.01% of Optiver Holding's portfolio in Q1 2026, its #2011 holding.
  • Optiver Holding first reported a position in Standard BioTools in Q3 2025 and has held it in 3 quarters since.
  • Optiver Holding's Standard BioTools position peaked at $5.02K in Q3 2025.
  • 155 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.